13 October 2017 : Clinical Research
Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer
DOI: 10.12659/MSM.904366
Med Sci Monit 2017; 23:4895-4900
HTML version available soon